Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas.

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas. / Hendel, Helle W; Daugaard, Soeren; Kjaer, Andreas.

In: Clinical Nuclear Medicine, Vol. 27, No. 9, 2002, p. 622-4.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Hendel, HW, Daugaard, S & Kjaer, A 2002, 'Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas.', Clinical Nuclear Medicine, vol. 27, no. 9, pp. 622-4. https://doi.org/10.1097/01.RLU.0000023879.58875.B1

APA

Hendel, H. W., Daugaard, S., & Kjaer, A. (2002). Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas. Clinical Nuclear Medicine, 27(9), 622-4. https://doi.org/10.1097/01.RLU.0000023879.58875.B1

Vancouver

Hendel HW, Daugaard S, Kjaer A. Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas. Clinical Nuclear Medicine. 2002;27(9):622-4. https://doi.org/10.1097/01.RLU.0000023879.58875.B1

Author

Hendel, Helle W ; Daugaard, Soeren ; Kjaer, Andreas. / Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas. In: Clinical Nuclear Medicine. 2002 ; Vol. 27, No. 9. pp. 622-4.

Bibtex

@article{4b1f5d10acce11ddb538000ea68e967b,
title = "Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas.",
abstract = "PURPOSE: The current study was designed to evaluate the role of planar bone scintigraphy in the diagnosis of sarcomatous change in osteochondromas (cartilaginous exostoses). MATERIALS AND METHODS: Histologically verified cases of chondrosarcoma and osteochondroma, in which Tc-99m bone scintigraphy was performed, were reviewed in a retrospective study. RESULTS: Twenty-two cases were evaluated. Of 11 cases with chondrosarcomas, 8 (73%) had clearly increased tracer uptake, whereas the remaining cases had normal or decreased tracer uptake. Of the 11 cases with osteochondromas, 8 (73%) had clearly increased tracer uptake, whereas the remaining cases had normal or decreased tracer uptake. No significant difference in the distribution of scintigraphic results was noted between the two pathoanatomic groups (p = 1). CONCLUSION: In conclusion, single standing planar bone scintigraphy has no value in distinguishing benign osteochondromas from malignant chondrosarcomas.",
author = "Hendel, {Helle W} and Soeren Daugaard and Andreas Kjaer",
note = "Keywords: Adult; Bone Neoplasms; Chondrosarcoma; Databases, Factual; Diagnosis, Differential; Humans; Middle Aged; Osteochondroma; Predictive Value of Tests; Retrospective Studies; Technetium; Tissue Distribution",
year = "2002",
doi = "10.1097/01.RLU.0000023879.58875.B1",
language = "English",
volume = "27",
pages = "622--4",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams & Wilkins",
number = "9",

}

RIS

TY - JOUR

T1 - Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas.

AU - Hendel, Helle W

AU - Daugaard, Soeren

AU - Kjaer, Andreas

N1 - Keywords: Adult; Bone Neoplasms; Chondrosarcoma; Databases, Factual; Diagnosis, Differential; Humans; Middle Aged; Osteochondroma; Predictive Value of Tests; Retrospective Studies; Technetium; Tissue Distribution

PY - 2002

Y1 - 2002

N2 - PURPOSE: The current study was designed to evaluate the role of planar bone scintigraphy in the diagnosis of sarcomatous change in osteochondromas (cartilaginous exostoses). MATERIALS AND METHODS: Histologically verified cases of chondrosarcoma and osteochondroma, in which Tc-99m bone scintigraphy was performed, were reviewed in a retrospective study. RESULTS: Twenty-two cases were evaluated. Of 11 cases with chondrosarcomas, 8 (73%) had clearly increased tracer uptake, whereas the remaining cases had normal or decreased tracer uptake. Of the 11 cases with osteochondromas, 8 (73%) had clearly increased tracer uptake, whereas the remaining cases had normal or decreased tracer uptake. No significant difference in the distribution of scintigraphic results was noted between the two pathoanatomic groups (p = 1). CONCLUSION: In conclusion, single standing planar bone scintigraphy has no value in distinguishing benign osteochondromas from malignant chondrosarcomas.

AB - PURPOSE: The current study was designed to evaluate the role of planar bone scintigraphy in the diagnosis of sarcomatous change in osteochondromas (cartilaginous exostoses). MATERIALS AND METHODS: Histologically verified cases of chondrosarcoma and osteochondroma, in which Tc-99m bone scintigraphy was performed, were reviewed in a retrospective study. RESULTS: Twenty-two cases were evaluated. Of 11 cases with chondrosarcomas, 8 (73%) had clearly increased tracer uptake, whereas the remaining cases had normal or decreased tracer uptake. Of the 11 cases with osteochondromas, 8 (73%) had clearly increased tracer uptake, whereas the remaining cases had normal or decreased tracer uptake. No significant difference in the distribution of scintigraphic results was noted between the two pathoanatomic groups (p = 1). CONCLUSION: In conclusion, single standing planar bone scintigraphy has no value in distinguishing benign osteochondromas from malignant chondrosarcomas.

U2 - 10.1097/01.RLU.0000023879.58875.B1

DO - 10.1097/01.RLU.0000023879.58875.B1

M3 - Journal article

C2 - 12192277

VL - 27

SP - 622

EP - 624

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 9

ER -

ID: 8465165